Cargando…
A Novel Cytotoxic Conjugate Derived from the Natural Product Podophyllotoxin as a Direct-Target Protein Dual Inhibitor
Natural products are the ideal basis for the design of novel efficient molecular entities. Podophyllotoxin, a naturally occurring cyclolignan, is an example of natural product which displays a high versatility from a biological activity point of view. Based on its unique chemical structure, differen...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571232/ https://www.ncbi.nlm.nih.gov/pubmed/32957517 http://dx.doi.org/10.3390/molecules25184258 |
_version_ | 1783597130160537600 |
---|---|
author | Hernández, Ángela-Patricia Díez, Paula García, Pablo A. Pérez-Andrés, Martín Ortega, Pablo Jambrina, Pablo G. Díez, David Castro, María Ángeles Fuentes, Manuel |
author_facet | Hernández, Ángela-Patricia Díez, Paula García, Pablo A. Pérez-Andrés, Martín Ortega, Pablo Jambrina, Pablo G. Díez, David Castro, María Ángeles Fuentes, Manuel |
author_sort | Hernández, Ángela-Patricia |
collection | PubMed |
description | Natural products are the ideal basis for the design of novel efficient molecular entities. Podophyllotoxin, a naturally occurring cyclolignan, is an example of natural product which displays a high versatility from a biological activity point of view. Based on its unique chemical structure, different derivatives have been synthesized presenting the original antitumoral properties associated with the compound, i.e., the tubulin polymerization inhibition and arising anti-topoisomerase II activity from structural modifications on the cyclolignan skeleton. In this report, we present a novel conjugate or hybrid which chemically combines both biological activities in one single molecule. Chemical design has been planned based in our lead compound, podophyllic aldehyde, as an inhibitor of tubulin polymerization, and in etoposide, an approved antitumoral drug targeting topoisomerase II. The cytotoxicity and selectivity of the novel synthetized hybrid has been evaluated in several cell lines of different solid tumors. In addition, these dual functional effects of the novel compound have been also evaluated by molecular docking approaches. |
format | Online Article Text |
id | pubmed-7571232 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75712322020-10-28 A Novel Cytotoxic Conjugate Derived from the Natural Product Podophyllotoxin as a Direct-Target Protein Dual Inhibitor Hernández, Ángela-Patricia Díez, Paula García, Pablo A. Pérez-Andrés, Martín Ortega, Pablo Jambrina, Pablo G. Díez, David Castro, María Ángeles Fuentes, Manuel Molecules Article Natural products are the ideal basis for the design of novel efficient molecular entities. Podophyllotoxin, a naturally occurring cyclolignan, is an example of natural product which displays a high versatility from a biological activity point of view. Based on its unique chemical structure, different derivatives have been synthesized presenting the original antitumoral properties associated with the compound, i.e., the tubulin polymerization inhibition and arising anti-topoisomerase II activity from structural modifications on the cyclolignan skeleton. In this report, we present a novel conjugate or hybrid which chemically combines both biological activities in one single molecule. Chemical design has been planned based in our lead compound, podophyllic aldehyde, as an inhibitor of tubulin polymerization, and in etoposide, an approved antitumoral drug targeting topoisomerase II. The cytotoxicity and selectivity of the novel synthetized hybrid has been evaluated in several cell lines of different solid tumors. In addition, these dual functional effects of the novel compound have been also evaluated by molecular docking approaches. MDPI 2020-09-17 /pmc/articles/PMC7571232/ /pubmed/32957517 http://dx.doi.org/10.3390/molecules25184258 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hernández, Ángela-Patricia Díez, Paula García, Pablo A. Pérez-Andrés, Martín Ortega, Pablo Jambrina, Pablo G. Díez, David Castro, María Ángeles Fuentes, Manuel A Novel Cytotoxic Conjugate Derived from the Natural Product Podophyllotoxin as a Direct-Target Protein Dual Inhibitor |
title | A Novel Cytotoxic Conjugate Derived from the Natural Product Podophyllotoxin as a Direct-Target Protein Dual Inhibitor |
title_full | A Novel Cytotoxic Conjugate Derived from the Natural Product Podophyllotoxin as a Direct-Target Protein Dual Inhibitor |
title_fullStr | A Novel Cytotoxic Conjugate Derived from the Natural Product Podophyllotoxin as a Direct-Target Protein Dual Inhibitor |
title_full_unstemmed | A Novel Cytotoxic Conjugate Derived from the Natural Product Podophyllotoxin as a Direct-Target Protein Dual Inhibitor |
title_short | A Novel Cytotoxic Conjugate Derived from the Natural Product Podophyllotoxin as a Direct-Target Protein Dual Inhibitor |
title_sort | novel cytotoxic conjugate derived from the natural product podophyllotoxin as a direct-target protein dual inhibitor |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571232/ https://www.ncbi.nlm.nih.gov/pubmed/32957517 http://dx.doi.org/10.3390/molecules25184258 |
work_keys_str_mv | AT hernandezangelapatricia anovelcytotoxicconjugatederivedfromthenaturalproductpodophyllotoxinasadirecttargetproteindualinhibitor AT diezpaula anovelcytotoxicconjugatederivedfromthenaturalproductpodophyllotoxinasadirecttargetproteindualinhibitor AT garciapabloa anovelcytotoxicconjugatederivedfromthenaturalproductpodophyllotoxinasadirecttargetproteindualinhibitor AT perezandresmartin anovelcytotoxicconjugatederivedfromthenaturalproductpodophyllotoxinasadirecttargetproteindualinhibitor AT ortegapablo anovelcytotoxicconjugatederivedfromthenaturalproductpodophyllotoxinasadirecttargetproteindualinhibitor AT jambrinapablog anovelcytotoxicconjugatederivedfromthenaturalproductpodophyllotoxinasadirecttargetproteindualinhibitor AT diezdavid anovelcytotoxicconjugatederivedfromthenaturalproductpodophyllotoxinasadirecttargetproteindualinhibitor AT castromariaangeles anovelcytotoxicconjugatederivedfromthenaturalproductpodophyllotoxinasadirecttargetproteindualinhibitor AT fuentesmanuel anovelcytotoxicconjugatederivedfromthenaturalproductpodophyllotoxinasadirecttargetproteindualinhibitor AT hernandezangelapatricia novelcytotoxicconjugatederivedfromthenaturalproductpodophyllotoxinasadirecttargetproteindualinhibitor AT diezpaula novelcytotoxicconjugatederivedfromthenaturalproductpodophyllotoxinasadirecttargetproteindualinhibitor AT garciapabloa novelcytotoxicconjugatederivedfromthenaturalproductpodophyllotoxinasadirecttargetproteindualinhibitor AT perezandresmartin novelcytotoxicconjugatederivedfromthenaturalproductpodophyllotoxinasadirecttargetproteindualinhibitor AT ortegapablo novelcytotoxicconjugatederivedfromthenaturalproductpodophyllotoxinasadirecttargetproteindualinhibitor AT jambrinapablog novelcytotoxicconjugatederivedfromthenaturalproductpodophyllotoxinasadirecttargetproteindualinhibitor AT diezdavid novelcytotoxicconjugatederivedfromthenaturalproductpodophyllotoxinasadirecttargetproteindualinhibitor AT castromariaangeles novelcytotoxicconjugatederivedfromthenaturalproductpodophyllotoxinasadirecttargetproteindualinhibitor AT fuentesmanuel novelcytotoxicconjugatederivedfromthenaturalproductpodophyllotoxinasadirecttargetproteindualinhibitor |